Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$440,961,969
-$44,606,729 QoQ
Shares Held
3,490,280
+0.2% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#45
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. GILD ranks #9 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $440,961,969 | 3,490,280 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $485,568,698 | 3,484,026 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $404,495,309 | 3,295,546 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $384,574,263 | 3,464,633 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $387,348,064 | 3,493,714 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $352,780,344 | 3,148,419 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $270,586,086 | 2,929,372 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $187,915,115 | 2,241,354 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $125,211,530 | 1,824,975 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $140,512,322 | 1,918,257 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $192,589,525 | 2,377,355 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $194,799,706 | 2,599,409 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $229,956,375 | 2,983,734 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $223,662,558 | 2,695,704 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $257,379,326 | 2,998,012 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $164,154,248 | 2,660,954 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $156,845,899 | 2,537,549 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $202,700,241 | 3,409,592 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $293,264,889 | 4,038,905 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $219,099,819 | 3,136,719 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $300,798,449 | 4,368,261 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $272,872,640 | 4,222,074 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $421,203,426 | 7,229,719 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $551,377,421 | 8,725,707 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $549,563,259 | 7,142,751 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,020,610,956 | 13,651,832 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||